八旬患者既往胸骨切开后瓣膜手术的远期生存与自评生活质量
本研究纳入2004至2023年间接受瓣膜再手术的934例八旬患者,中位年龄83岁,29%为女性。手术死亡率6%,中位生存5.6年,与年龄性别匹配的美国人群5.9年相近;随访1、3、5年时多数受访者自评总体健康状况和体力活动水平显著改善。结论认为高龄本身不应成为瓣膜病再手术的禁忌。
要点
- 八旬患者瓣膜再手术手术死亡率6%,中位生存5.6年,与匹配人群5.9年接近。
- 随访1、3、5年多数受访者自评总体健康和体力活动显著改善。
- 肾功能衰竭、房颤史、外周血管病、脑血管病、中重度慢性肺病及合并三尖瓣手术与远期死亡独立相关。
核心结论
- 八旬患者重复瓣膜手术可获得良好的短期和长期结局,年龄本身不应视为瓣膜病再手术的禁忌。
研究设计与样本
- 回顾性队列研究,纳入2004至2023年间接受心脏瓣膜再手术的934例八旬患者,中位年龄83岁,29%为女性。
主要发现
- 手术死亡率6%,总住院时间6天(4-9天)。
- 中位生存5.6年,性别年龄匹配的美国人群为5.9年。
- 随访1、3、5年时多数调查受访者报告总体健康状况和体力活动水平显著改善。
- 肾功能衰竭(HR 2.1,P < .001)、房颤史(HR 1.2,P = .029)、外周血管病(HR 1.2,P = .026)、脑血管病(HR 1.2,P = .022)、中重度慢性肺病(HR 1.7,P < .001)及合并三尖瓣手术(HR 1.5,P = .0022)与远期死亡独立相关。
关键数值与推荐
- 再手术类型:单纯手术72%(主动脉瓣58%、二尖瓣10%、三尖瓣4%),多瓣膜手术16%,瓣膜加冠状动脉旁路移植12%。
- 既往手术:单纯CABG 53%,单纯瓣膜27%,瓣膜加CABG 17%,其他3%。
临床怎么用
- 对八旬瓣膜病患者,既往胸骨切开不应仅因年龄而排除再手术,应结合肾功能、房颤、外周血管病、脑血管病、慢性肺病及是否需合并三尖瓣手术等风险因素综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent advances in transcatheter valve techniques often compete with open cardiac operations in managing high-risk patients with valvular disease, especially in the elderly. This study assessed late survival and quality of life after valvular surgery in octogenarians with prior sternotomy. METHODS: We identified octogenarians who underwent cardiac valve reoperations between 2004 and 2023. Study end points were long-term mortality, long-term self-reported physical activity, and general health status. RESULTS: A total of 934 octogenarians (median age, 83 years; 29% women) had valve reoperations. Reoperations were isolated procedures in 72% (aortic [58%], mitral [10%], and tricuspid [4%]), multiple valve procedures in 16%, and valve + coronary artery bypass graft (CABG) in 12%. Previous operations were isolated CABG in 53%, isolated valve in 27%, valve + CABG in 17%, and others in 3%. Operative mortality was 6%. Total hospital stay was 6 days (4-9 days). Median survival was 5.6 years in this cohort compared with 5.9 years for a sex- and age-matched US population. At 1-, 3-, and 5-year follow-up, most survey respondents reported significant improvement in their general health status and physical activity levels. Renal failure (hazard ratio [HR], 2.1; P < .001), history of atrial fibrillation (HR, 1.2; P = .029), peripheral vascular disease (HR, 1.2; P = .026), cerebrovascular disease (HR, 1.2; P = .022), moderate or severe chronic lung disease (HR, 1.7; P < .001), and concomitant tricuspid valve surgery (HR, 1.5; P = .0022) were independently associated with increased late mortality. CONCLUSIONS: Repeated valve surgery in octogenarians can be performed with excellent short- and long-term outcomes. Age alone should not be a contraindication to reoperation for patients requiring intervention for valvular disease.
引用
- Sawma T, Schaff HV, Arghami A, et al. Late Survival and Self-Reported Quality of Life in Octogenarians With Prior Sternotomy Undergoing Valvular Surgery. Ann Thorac Surg. 2025. PMID: 40912622. doi:10.1016/j.athoracsur.2025.08.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。